Free public records show Cheplapharm in 5 of the markets we cover. It is not a key player in our research.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
11 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
Markets we cover where free public records show Cheplapharm: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Cheplapharm is in.
Stories on the topics Cheplapharm works in.
170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and…
Read
Depression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress…
Read
More than 300 million operations are done each year, and many no longer need an overnight stay. Ambulatory…
Read